ZBH · 8-K · 20261104PR446145

Regulatory Risk

ZIMMER BIOMET HOLDINGS, INC. · 2026-11-04 · Importance 57 · Surprise 64

The European Union Medical Device Regulation adds premarket and postmarket requirements for medical devices, with transition deadlines extended to December 2027 or 2028 depending on the legacy device’s risk class. Zimmer Biomet reported $13.4 million of incremental EU MDR compliance costs in the nine months ended September 30, 2025, but none in the comparable 2026 period. The company said it does not expect significant incremental costs related to these regulations starting January 1, 2026.